Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

34.2K
The Concept of Multiple Allelism
34.2K
Humoral Immune Responses01:36

Humoral Immune Responses

72.8K
Overview
72.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

947
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
947
Rh Blood Group01:19

Rh Blood Group

1.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Hypersensitivities01:30

Hypersensitivities

673
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
673

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A global survey of blood transfusion practices for patients with sickle cell disease.

Transfusion·2026
Same author

Perioperative management of adult sickle cell disease patients requiring cardiac surgery: A 25-year experience in a referral center.

Anaesthesia, critical care & pain medicine·2026
Same author

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.

American journal of hematology·2026
Same author

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

HemaSphere·2026
Same author

A Novel Plasma Heme Assay Reveals Disease Severity in Beta-Thalassemia and Sickle Cell Anemia.

American journal of hematology·2026
Same author

Patient blood management and surgery: Impact of new surgical techniques on transfusion needs.

Vox sanguinis·2026

Related Experiment Video

Updated: Jul 9, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K

Alloimmunization and hyperhemolysis in sickle cell disease.

France Pirenne1,2, Corinne Pondarré1,3

  • 1Université Paris Est Créteil, INSERM U955, IMRB, Créteil, France.

Hematology. American Society of Hematology. Education Program
|December 9, 2023
PubMed
Summary

Alloimmunization and delayed hemolytic transfusion reactions (DHTR) complicate sickle cell disease (SCD) transfusions. Careful management, including antigen-matched blood and immunosuppression, is crucial to prevent and treat these life-threatening complications.

More Related Videos

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

9.9K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

Related Experiment Videos

Last Updated: Jul 9, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.7K
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

9.9K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Immunology

Background:

  • Alloimmunization and delayed hemolytic transfusion reactions (DHTR) are significant challenges in sickle cell disease (SCD) management.
  • Patients with SCD, often of African ancestry, face increased risk due to blood group antigen disparities and frequent transfusions.
  • DHTR in SCD is a potentially life-threatening complication requiring careful consideration of transfusion necessity.

Purpose of the Study:

  • To highlight the risks of alloimmunization and DHTR in sickle cell disease patients.
  • To discuss strategies for managing transfusions in at-risk SCD patients.
  • To outline monitoring and treatment protocols for DHTR in SCD.

Main Methods:

  • Review of risk factors for alloimmunization and DHTR in SCD, including genetic background, clinical state, and transfusion practices.
  • Discussion of balancing transfusion benefits against risks in patients with SCD.
  • Emphasis on monitoring and management strategies for post-transfusion complications.

Main Results:

  • Identified blood group polymorphism, inflammatory state, and acute transfusion needs as key risk factors for alloimmunization and DHTR in SCD.
  • Stressed the importance of individualized risk-benefit assessment for transfusions in SCD.
  • Highlighted the efficacy of antigen-matched transfusions, immunosuppression, and close monitoring in preventing and managing DHTR.

Conclusions:

  • Transfusion management in SCD requires a delicate balance between therapeutic necessity and the risk of alloimmunization and DHTR.
  • Protocols involving antigen-matched blood, immunosuppressive therapy, and vigilant post-transfusion monitoring are essential.
  • Early diagnosis and management of hyperhemolysis, including avoiding retransfusion and considering anticomplement therapy, are critical for severe cases. Hematopoietic stem cell transplantation is an option for severe disease, though transfusion management remains complex.